Taribavirin
Taribavirin
Taribavirin (pronounced: tah-ri-ba-vi-rin) is an antiviral drug used in the treatment of Hepatitis C. It is a prodrug of ribavirin, which means it is metabolically converted into the active drug ribavirin in the body.
Etymology
The name "Taribavirin" is derived from the chemical structure of the drug. "Tari" is short for "taribavirin", which is a combination of parts of the words "ribavirin" and "tartrate". "Bavirin" is derived from "ribavirin", the active drug that taribavirin is converted into in the body.
Usage
Taribavirin is used in the treatment of chronic Hepatitis C, a viral infection that causes inflammation of the liver. It is often used in combination with other antiviral drugs, such as peginterferon alfa-2b or peginterferon alfa-2a, to increase the effectiveness of treatment.
Mechanism of Action
As a prodrug of ribavirin, taribavirin is metabolically converted into ribavirin in the body. Ribavirin then works by inhibiting the replication of the hepatitis C virus, thereby reducing the amount of virus in the body.
Related Terms
External links
- Medical encyclopedia article on Taribavirin
- Wikipedia's article - Taribavirin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski